The internet has connected us in a way never before seen in history: we can now rely on other’s people experiences to guide our own. Whether it is...

From pharmaceuticals to financial services, the motives that drive outsourcing are fundamental. Top among them are perceived cost savings, improved...

Working on the Rare Disease Science Challenge has shown me that everybody wants to support rare disease in many different ways, which is how the...

Last week we blogged about the growing trend in pharmaceutical outsourcing. When people hear the word “outsourcing”, many assume that means that...

Washington University geneticist Dr. Jimmy Lin’s Rare Genomics Institute and Scientist of San Diego have announced the winners of about $500,000 in...

The Be HEARD Rare Disease Science Challenge is entering its next phase. After 77 applicants covering 67 rare diseases, we have decided on service...

By some estimates, the pharmaceutical outsourcing market could grow to $65 billion by 2018, fueled by a compound annual growth rate of nearly 15...

This article discusses how the pharmaceutical industry can leverage its competencies in outsourcing to accelerate time to market, improve quality...

It’s not hard to find articles, blog posts, or market reports these days that state contract research organizations, and outsourcing in general, is...

Last month we ran a series of blog posts about next generation sequencing. Among the topics discussed were the limitations of next generation...